Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lafrenz

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Munchener Medizinische Wochenschrift (1950)|November 16, 1973
[New aspects of the treatment of toxoplasmosis (author's transl)]M Lafrenz, K Ziegler, R Sänger, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 4, 2010
[Knowledge of school pupils about the HIV/AIDS topic at selected schools in Mecklenburg-Western Pomerania]M Sachsenweger, G Kundt, G Hauk, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter studyM Wiese, F Berr, M Lafrenz, et al.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2002
[Histoplasmosis group disease in bat researchers returning from Cuba]K Erkens, M Lademann, K Tintelnot, et al.
Deutsche Medizinische Wochenschrift (1946)|October 28, 2005
[A case of autochthonous early summer meningoencephalitis in Mecklenberg-Western Pomerania]C J Hemmer, M Littmann, M Löbermann, et al.
Journal of Medical Virology|July 1, 1995
Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative studyC Goilav, J Zuckerman, M Lafrenz, et al.
The Journal of Infection|March 1, 1997
Persistence of antibodies after inactivated hepatitis A vaccines in a comparative studyC Goilav, J Zuckerman, M Lafrenz, et al.
Digestion|March 8, 2000
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis CG Teuber, T Berg, R M Hoffmann, et al.
Liver|February 13, 2001
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trialT Berg, R M Hoffmann, G Teuber, et al.
Journal of Viral Hepatitis|October 12, 2007
Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety TrialTh Witthöft, B Möller, K H Wiedmann, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Munchener Medizinische Wochenschrift (1950)|November 16, 1973
[New aspects of the treatment of toxoplasmosis (author's transl)]M Lafrenz, K Ziegler, R Sänger, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 4, 2010
[Knowledge of school pupils about the HIV/AIDS topic at selected schools in Mecklenburg-Western Pomerania]M Sachsenweger, G Kundt, G Hauk, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter studyM Wiese, F Berr, M Lafrenz, et al.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2002
[Histoplasmosis group disease in bat researchers returning from Cuba]K Erkens, M Lademann, K Tintelnot, et al.
Deutsche Medizinische Wochenschrift (1946)|October 28, 2005
[A case of autochthonous early summer meningoencephalitis in Mecklenberg-Western Pomerania]C J Hemmer, M Littmann, M Löbermann, et al.
Journal of Medical Virology|July 1, 1995
Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative studyC Goilav, J Zuckerman, M Lafrenz, et al.
The Journal of Infection|March 1, 1997
Persistence of antibodies after inactivated hepatitis A vaccines in a comparative studyC Goilav, J Zuckerman, M Lafrenz, et al.
Digestion|March 8, 2000
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis CG Teuber, T Berg, R M Hoffmann, et al.
Liver|February 13, 2001
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trialT Berg, R M Hoffmann, G Teuber, et al.
Journal of Viral Hepatitis|October 12, 2007
Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety TrialTh Witthöft, B Möller, K H Wiedmann, et al.
Pageof 5